NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system (CNS) disorders, ...
Scientists have zeroed in on a critical weak spot behind a rare but devastating brain autoimmune disorder often known as ...
Milsaperidone is an active metabolite of iloperidone ...
When lithium or valproate aren't enough, ‘add-on’ treatments like atypical antipsychotics can help. Discover 7 options to discuss with your doctor.
Patients with major depressive disorder and patients with inflammatory skin diseases like atopic dermatitis share similar immune abnormalities, notably in the Th2 pathway, according to a study ...
Letter, Hantsoo explained one of her current studies along with her thoughts on the changing landscape of reproductive health.